SEB Asset Management AB Invests $6.30 Million in Agilent Technologies, Inc. $A

SEB Asset Management AB purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 55,270 shares of the medical research company’s stock, valued at approximately $6,300,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Agilent Technologies by 4.3% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after purchasing an additional 24,687 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares during the period. CCLA Investment Management raised its holdings in shares of Agilent Technologies by 1.9% during the fourth quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company’s stock valued at $142,542,000 after buying an additional 19,518 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Agilent Technologies by 20.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock valued at $7,269,000 after buying an additional 9,236 shares during the last quarter. Finally, Crossmark Global Holdings Inc. boosted its position in shares of Agilent Technologies by 39.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock worth $4,615,000 after buying an additional 9,615 shares during the period. 87.41% of the stock is currently owned by institutional investors.

Agilent Technologies Stock Up 2.1%

NYSE A opened at $133.04 on Wednesday. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The company has a market capitalization of $37.58 billion, a P/E ratio of 26.72, a PEG ratio of 2.31 and a beta of 1.25. The company’s 50 day simple moving average is $128.27 and its 200 day simple moving average is $125.47. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company’s revenue was up 10.0% compared to the same quarter last year. During the same period last year, the company posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities research analysts expect that Agilent Technologies, Inc. will post 6.01 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s payout ratio is currently 20.48%.

Analyst Ratings Changes

Several research firms recently commented on A. Robert W. Baird raised their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. HSBC reduced their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Royal Bank Of Canada assumed coverage on Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price target for the company. TD Cowen lifted their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Finally, Piper Sandler began coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $159.35.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.